The health system, taking part in HealthLeaders’ AI in Clinical Care Mastermind program, says AI has the potential to ...

Dr. Fong has focused on gene therapy for over two decades, engineering viruses and immune cells to kill cancer. His City of Hope team developed CF33, a cancer-fighting virus that has been shown to ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

Researchers find new way to detect early signs of pancreatic cancer The discovery could transform outcomes for thousands of patients Daisuke Suzuki, Falk Hildebrand Wednesday 25 June 2025 15:49 BST ...

Urgent pancreatic cancer tests will be offered on the NHS for those who are most at risk. GPs taking part in the NHS pilot will reach out to patients who have the key early warning signs of ...

Immuneering Corporation (NASDAQ:IMRX) stock rose 7% on Monday after the clinical-stage oncology company reported positive survival data from its ongoing Phase 2a trial evaluating atebimetinib in ...

City of Hope co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment ...

City of Hope announced Hope LLM, a novel generative AI platform that leverages multiple commercial and open-source AI models.

City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and ...

LOS ANGELES, June 17, 2025--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named a Top 5 ...